Gliosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 12
Ph III recruiting: 0
Growth YoY: —
Industry share: 3%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 43%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (55)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03014804	Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma	withdrawn	Phase 2	0	Jonsson Comprehensive Cancer CenterOTHER	1	Jul 24, 2020	clinicaltrials
NCT02521090	EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma	withdrawn	Phase 1 / Phase 2	0	Barbara Ann Karmanos Cancer InstituteOTHER	0	Feb 15, 2016